more pros from msc - but little detail . For those folling this...

more pros from msc - but little detail . For those folling this saga ....there has just been another update released , as well as the quarterly report.

1) The revenue forcast imply a gross margin on sales of only 30 % - I would have thought this is very low for this type of operation , and relies on the ability to make and sell large volumes of product to ever make any money. As we all know MSC doesn't have such a flash track record in that dept.

2) Quarterly report - No mention of cash statements or working capital ....

This will be an interesting journey for the patient holders ....... a journey with a fairly predictable end I suspect.